BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9679767)

  • 21. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung.
    Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K
    Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
    Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
    Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
    Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
    J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.
    Grady WM; Willis JE; Trobridge P; Romero-Gallo J; Munoz N; Olechnowicz J; Ferguson K; Gautam S; Markowitz SD
    Int J Cancer; 2006 Feb; 118(3):600-8. PubMed ID: 16108056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.
    Park K; Kim SJ; Bang YJ; Park JG; Kim NK; Roberts AB; Sporn MB
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8772-6. PubMed ID: 8090721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
    Baldwin RL; Friess H; Yokoyama M; Lopez ME; Kobrin MS; Büchler MW; Korc M
    Int J Cancer; 1996 Jul; 67(2):283-8. PubMed ID: 8760600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.
    Kleeff J; Wildi S; Friess H; Korc M
    Pancreas; 1999 May; 18(4):364-70. PubMed ID: 10231841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
    Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma.
    Kim JW; Kim HS; Kim IK; Kim MR; Cho EY; Kim HK; Lee JM; Namkoong SE
    Gynecol Oncol; 1998 Jun; 69(3):230-6. PubMed ID: 9648593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
    Franchi A; Gallo O; Sardi I; Santucci M
    J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.